Viewing Study NCT01738360


Ignite Creation Date: 2025-12-25 @ 2:16 AM
Ignite Modification Date: 2026-07-13 @ 11:14 AM
Study NCT ID: NCT01738360
Status: TERMINATED
Last Update Posted: 2016-01-06
First Post: 2012-11-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 2a Study Evaluating the Arsenic Trioxide (ATO) in Systemic Lupus (SLE) (Protocol LUPSENIC)
Sponsor: Nantes University Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Systemic Lupus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Arsenic trioxide View
None Systemic Lupus View
None clinically View
None biologically active View